Neurotransmitter action in osteoblasts: Expression of a functional system for serotonin receptor activation and reuptake

被引:169
作者
Bliziotes, MM
Eshleman, AJ
Zhang, XW
Wiren, KM
机构
[1] Portland VA Med Ctr, Portland, OR USA
[2] Oregon Hlth & Sci Univ, Portland, OR USA
关键词
bone; osteoblast; neurotransmitter; serotonin; receptor; transporter;
D O I
10.1016/S8756-3282(01)00593-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neurotransmitter regulation of bone metabolism has been the subject of increasing interest and investigation. Because serotonin (5-HT) plays a role as a regulator of craniofacial morphogenesis, we investigated the expression and function of 5-HT receptors and the 5-HT transporter (5-HTT) in bone. Primary cultures of rat osteoblasts (rOB) and a variety of clonal osteoblastic cell lines, including ROS 17/2.8, UMR 106-H5, and Pyla, showed mRNA expression for 5-HTT as well as the 5-HT1A, 5-HT1D, 5-HT2A, and 5-HT2B, receptors by reverse transcription-polymerase chain reaction (RT-PCR) analysis. Protein expression of the 5-HT1A, 5-HT2A, and 5-HT2B receptors was confirmed by immunoblot. 5-HTT binding sites were assessed in ROS 17/2.8 and UMR 106-H5 cells by binding of the stable cocaine analog [I-125]RTI-55, which showed a relatively high density of nanomolar affinity binding sites. Imipramine and fluoxetine, antagonists with specificity for 5-HTT, showed the highest potency to antagonize [I-125]RTI-55 binding in ROS and UMR cells. GBR-12935, a relatively selective dopamine transporter antagonist, had a much lower potency, as did desipramine, a selective norepinephrine transporter antagonist. The maximal [H-3]5-HT uptake rate in ROS cells was 110 pmol/10 min per well, with a K-m value of 1.13 mu mol/L. Imipramine and fluoxetine inhibited specific [H-3]5-HT uptake with IC50 values in the nanomolar range. In normal differentiating rOB cultures, 5-HTT functional activity was observed initially at day 25, and activity increased almost eightfold by day 31. In mature rOB cultures, the estimated density of [I-125]RTI-55 binding sites was 600 fmol/mg protein. Functional downregulation of transporter activity was assessed after PMA treatment, which caused a significant 40% reduction in the maximal uptake rate of [H-3]5-HT, an effect that was prevented by pretreatment with staurosporine. The affinity of 5-HT for the transporter was significantly increased following PMA treatment. We assessed the functional significance of expression of the 5-HT receptors by investigating the interaction between 5-HT and parathyroid hormone (PTH) signaling. 5-HT potentiates the PTH-induced increase in AP-1 activity in UMR cells. These results demonstrate that osteoblastic cells express a functional serotonin system, with mechanisms for responding to and regulating uptake of 5-HT. (C) 2001 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:477 / 486
页数:10
相关论文
共 58 条
  • [1] ABRAMOWSKI D, 1995, J NEUROCHEM, V65, P782
  • [2] ACTIVATORS OF PROTEIN-KINASE-C DECREASE SEROTONIN TRANSPORT IN HUMAN PLATELETS
    ANDERSON, GM
    HORNE, WC
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1137 (03) : 331 - 337
  • [3] Molecular characterization of antipeptide antibodies against the 5-HT1A receptor: evidence for state-dependent antibody binding
    Anthony, TE
    Azmitia, EC
    [J]. MOLECULAR BRAIN RESEARCH, 1997, 50 (1-2): : 277 - 284
  • [4] FACTORS THAT PROMOTE PROGRESSIVE DEVELOPMENT OF THE OSTEOBLAST PHENOTYPE IN CULTURED FETAL-RAT CALVARIA CELLS
    ARONOW, MA
    GERSTENFELD, LC
    OWEN, TA
    TASSINARI, MS
    STEIN, GS
    LIAN, JB
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 143 (02) : 213 - 221
  • [5] ANTIPEPTIDE ANTIBODIES AGAINST THE 5-HT1A RECEPTOR
    AZMITIA, EC
    YU, I
    AKBARI, HM
    KHECK, N
    WHITAKERAZMITIA, PM
    MARSHAK, DR
    [J]. JOURNAL OF CHEMICAL NEUROANATOMY, 1992, 5 (04) : 289 - 298
  • [6] BAILEY LJ, 1988, J CRAN GENET DEV BIO, V8, P167
  • [7] Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant
    Bender, E
    Pindon, A
    van Oers, I
    Zhang, YB
    Gommeren, W
    Verhasselt, P
    Jurzak, M
    Leysen, J
    Luyten, W
    [J]. JOURNAL OF NEUROCHEMISTRY, 2000, 74 (02) : 478 - 489
  • [8] CHANGES IN INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN EXPRESSION AND SECRETION DURING THE PROLIFERATION, DIFFERENTIATION, AND MINERALIZATION OF PRIMARY CULTURES OF RAT OSTEOBLASTS
    BIRNBAUM, RS
    WIREN, KM
    [J]. ENDOCRINOLOGY, 1994, 135 (01) : 223 - 230
  • [9] CHANGES IN IGF-I AND IGF-II EXPRESSION AND SECRETION DURING THE PROLIFERATION AND DIFFERENTIATION OF NORMAL RAT OSTEOBLASTS
    BIRNBAUM, RS
    BOWSHER, RR
    WIREN, KM
    [J]. JOURNAL OF ENDOCRINOLOGY, 1995, 144 (02) : 251 - 259
  • [10] SUBSTANCE-P-IMMUNOREACTIVE AND CGRP-IMMUNOREACTIVE NERVES IN BONE
    BJURHOLM, A
    KREICBERGS, A
    BRODIN, E
    SCHULTZBERG, M
    [J]. PEPTIDES, 1988, 9 (01) : 165 - 171